IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i7p4137-d783987.html
   My bibliography  Save this article

Cardiovascular Outcomes among Combustible-Tobacco and Electronic Nicotine Delivery System (ENDS) Users in Waves 1 through 5 of the Population Assessment of Tobacco and Health (PATH) Study, 2013–2019

Author

Listed:
  • Martin C. Mahoney

    (Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA)

  • Cheryl Rivard

    (Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA)

  • Heather L. Kimmel

    (National Institute on Drug Abuse, National Institutes of Health, Bethesda, MS 20892, USA)

  • Hoda T. Hammad

    (Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA)

  • Eva Sharma

    (Westat, Rockville, MD 20850, USA)

  • Michael J. Halenar

    (Westat, Rockville, MD 20850, USA)

  • Jim Sargent

    (The C. Everette Koop Institute at Dartmouth, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA)

  • K. Michael Cummings

    (Medical University of South Carolina, Charleston, SC 29425, USA)

  • Ray Niaura

    (NYU School of Global Public Health, New York, NY 10003, USA)

  • Maciej L. Goniewicz

    (Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA)

  • Maansi Bansal-Travers

    (Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA)

  • Dorothy Hatsukami

    (University of Minnesota, Minneapolis, MN 55414, USA)

  • Diann Gaalema

    (University of Vermont, Burlington, VT 05404, USA)

  • Geoffrey Fong

    (University of Waterloo, Waterloo, ON N2L 3G1, Canada)

  • Shannon Gravely

    (University of Waterloo, Waterloo, ON N2L 3G1, Canada)

  • Carol H. Christensen

    (Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA)

  • Ryan Haskins

    (Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA)

  • Marushka L. Silveira

    (National Institute on Drug Abuse, National Institutes of Health, Bethesda, MS 20892, USA
    Kelly Government Solutions, Troy, MI 48084, USA)

  • Carlos Blanco

    (National Institute on Drug Abuse, National Institutes of Health, Bethesda, MS 20892, USA)

  • Wilson Compton

    (National Institute on Drug Abuse, National Institutes of Health, Bethesda, MS 20892, USA)

  • Cassandra A. Stanton

    (Westat, Rockville, MD 20850, USA)

  • Andrew Hyland

    (Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA)

Abstract

Background: Prior studies have not clearly established risk of cardiovascular disease (CVD) among smokers who switch to exclusive use of electronic nicotine delivery systems (ENDS). We compared cardiovascular disease incidence in combustible-tobacco users, those who transitioned to ENDS use, and those who quit tobacco with never tobacco users. Methods: This prospective cohort study analyzes five waves of Population Assessment of Tobacco and Health (PATH) Study data, Wave 1 (2013–2014) through Wave 5 (2018–2019). Cardiovascular disease (CVD) incidence was captured over three intervals (Waves 1 to 3, Waves 2 to 4, and Waves 3 to 5). Participants were adults (40+ years old) without a history of CVD for the first two waves of any interval. Change in tobacco use status, from exclusive past 30 day use of any combustible-tobacco product to either exclusive past 30 day ENDS use, dual past 30 day use of ENDS and combustible-tobacco, or no past 30 day use of any tobacco, between the first two waves of an interval was used to predict onset of CVD between the second and third waves in the interval. CVD incidence was defined as a new self-report of being told by a health professional that they had congestive heart failure, stroke, or a myocardial infarction. Generalized estimating equation (GEE) analyses combined 10,548 observations across intervals from 7820 eligible respondents. Results: Overall, there were 191 observations of CVD among 10,548 total observations (1.7%, standard error (SE) = 0.2), with 40 among 3014 never users of tobacco (1.5%, SE = 0.3). In multivariable models, CVD incidence was not significantly different for any tobacco user groups compared to never users. There were 126 observations of CVD among 6263 continuing exclusive combustible-tobacco users (adjusted odds ratio [AOR] = 1.44; 95% confidence interval (CI) 0.87–2.39), 15 observations of CVD among 565 who transitioned to dual use (AOR = 1.85; 0.78–4.37), and 10 observations of CVD among 654 who quit using tobacco (AOR = 1.18; 0.33–4.26). There were no observations of CVD among 53 who transitioned to exclusive ENDS use. Conclusions: This study found no difference in CVD incidence by tobacco status over three 3 year intervals, even for tobacco quitters. It is possible that additional waves of PATH Study data, combined with information from other large longitudinal cohorts with careful tracking of ENDS use patterns may help to further clarify this relationship.

Suggested Citation

  • Martin C. Mahoney & Cheryl Rivard & Heather L. Kimmel & Hoda T. Hammad & Eva Sharma & Michael J. Halenar & Jim Sargent & K. Michael Cummings & Ray Niaura & Maciej L. Goniewicz & Maansi Bansal-Travers , 2022. "Cardiovascular Outcomes among Combustible-Tobacco and Electronic Nicotine Delivery System (ENDS) Users in Waves 1 through 5 of the Population Assessment of Tobacco and Health (PATH) Study, 2013–2019," IJERPH, MDPI, vol. 19(7), pages 1-10, March.
  • Handle: RePEc:gam:jijerp:v:19:y:2022:i:7:p:4137-:d:783987
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/7/4137/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/1660-4601/19/7/4137/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Martin C. Mahoney & Cheryl Rivard & Hoda T. Hammad & Carlos Blanco & James Sargent & Heather L. Kimmel & Baoguang Wang & Michael J. Halenar & Jueichuan Connie Kang & Nicolette Borek & K. Michael Cummi, 2021. "Cardiovascular Risk Factor and Disease Measures from the Population Assessment of Tobacco and Health (PATH) Study," IJERPH, MDPI, vol. 18(14), pages 1-12, July.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.

      Corrections

      All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:7:p:4137-:d:783987. See general information about how to correct material in RePEc.

      If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

      If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

      If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

      For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

      Please note that corrections may take a couple of weeks to filter through the various RePEc services.

      IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.